HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX)

CUSIP: 427746102

Q4 2024 13F Holders as of 31 Dec 2024

Security type / class
Equity / Common Stock, par value $0.01 per share
Total 13F shares
114,941,581
Total 13F value
$175,829,179
Holder snapshot 6 visible 7 signals
Share change
-6,938,779
Put/Call ratio
1.6%
SEC-reported price per share
$1.53
Number of holders
161
Value change
-$13,146,397
Number of buys
61
Open additional details 1 more signal available
Number of sells
82
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
182,615,507

Security key

427746102

Report period

Q4 2024

Institutions

161

Top holders

10

HRTX full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2025 Previous quarter: Q3 2024 HERON THERAPEUTICS, INC. /DE/ SEC filings HERON THERAPEUTICS, INC. /DE/ company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Rubric Capital Management LP
Disclosed value leader
Rubric Capital Management LP
Comparable rows
15/15
Latest evidence
30 Sep 2024
13F 3/4/5 Lead comparable stake: 15% Showing 1-6 of 15 holder rows.

Quick read

Rubric Capital Management LP leads the comparable SEC ownership view at 15%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Rubric Capital Management LP's linked filing trail.
Comparable ownership Top 5
Rubric Capital Management LP 15%
ADAGE CAPITAL PARTNERS GP, L.L.C. 4.8%
VANGUARD GROUP INC 4.8%
BlackRock, Inc. 4.7%
Velan Capital Investment Manageme... 3.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Rubric Capital Management LP
13F
Company
13F
15%
$53,159,871
26,713,503 shares
 — 30 Sep 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
4.8%
$17,611,500
8,850,000 shares
 — 30 Sep 2024
VANGUARD GROUP INC
13F
Company
13F
4.8%
$17,353,150
8,720,176 shares
 — 30 Sep 2024
BlackRock, Inc.
13F
Company
13F
4.7%
$16,983,790
8,534,567 shares
 — 30 Sep 2024
Velan Capital Investment Management LP
13F 3/4/5
Company · Other*
13F 3/4/5
3.8%
$13,903,621
6,986,744 shares
 — 30 Sep 2024
Tejara Capital Ltd
13F
Company
13F
2.9%
$10,558,574
5,305,816 shares
 — 30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
161
Shares
114,941,581
Rows available
161
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
169
Q4 2024 holders
161
Holder diff
-8
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 value Q4 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .